SecBot SecBot
COURT-RULING ·Filed Mar 30, 2026

JNJ

JANSSEN
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago CourtCourt Ruling · ecf.njd.uscourts.gov
Court ruling (district)
Actionable Insight • Neutral

Monitor for subsequent filings or docket updates in this case for material developments; no immediate financial or operational impact can be assessed from current information.

DirectionNeutral
Confidencelow
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$242.34
T+0 close · Mar 30, 2026 · via day close
Latest settled
−0.55%
T+60 · $241.00
Vs SPY
−16.58%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 30 $242.34entry
  2. T+1 · 8mo ago +0.84%α −2.05% · $244.38
  3. T+5 · 7mo ago −1.65%α −5.96% · $238.33
  4. T+20 · 7mo ago −6.06%α −18.66% · $227.65
  5. T+60 · 5mo ago −0.55%α −16.58% · $241.00
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable

Court Ruling Details

Court
United States District Court for the District of New Jersey
Court Level
District
Case Type
other
Ruling Type
other
Outcome
NULL
Precedent Risk
LOW

Key Facts

  • Case: Snyder et al v. Janssen Pharmaceuticals, Inc. et al
  • Filed in United States District Court for the District of New Jersey on 2026-03-30
  • Janssen Pharmaceuticals, Inc. is a subsidiary of Johnson & Johnson (JNJ)

Financial Impact

Unknown, no financial details available in provided documents

Risk Factors

  • Potential for future adverse rulings if the case proceeds on product liability or marketing claims, which are common in pharmaceutical litigation
  • Precedent risk if this case evolves into a class action or involves off-label promotion or opioid-related allegations

Market Snapshot

Price
$242.00
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
59% bullish (32 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-6k5omeby-JNJ

Track record

21 reports on JNJ

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +13.24% at T+60 after the May 13, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry $289.75 Now $282.55 −2.48% settles Feb 12
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $283.52 Now $282.55 −0.34% settles Feb 10
  3. Oct 13, 20264w ago 8-K Mixed 6/10 Entry $248.61 Now $282.55 +13.65% settles Jan 8
  4. Sep 30, 20266w ago Court Ruling Bullish 6/10 Entry $258.66 Now $282.55 +9.24% settles Dec 28
  5. Sep 24, 20267w ago Court Ruling Neutral 3/10 Entry $271.22 Now $282.55 +4.18% settles Dec 21
  6. Sep 9, 20269w ago Court Ruling Neutral 1/10 Entry $266.35 Now $282.55 +6.08% settles Dec 4
  7. Aug 18, 202612w ago Insider Cluster Neutral 2/10 Entry $273.41 to $283.52 Now $282.55 +3.34% ▲ +3.70% +5.25% vs SPY
  8. Aug 14, 202613w ago Insider Cluster Neutral 2/10 Entry $262.37 to $280.78 Now $282.55 +7.69% ▲ +7.02% +9.96% vs SPY
  9. Aug 7, 202614w ago Insider Cluster Neutral 3/10 Entry $261.81 to $266.17 Now $282.55 +7.92% ▲ +1.67% +4.08% vs SPY
  10. Aug 7, 202614w ago Court Ruling Bearish 4/10 Entry $261.81 to $266.17 Now $282.55 −7.92% ▼ −1.67% −4.08% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens Wed (11h 2m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · ecf.njd.uscourts.gov Report published Mar 30, 2026